TP63 and metastatic malignant neoplasm in the lymph nodes: In addition, a comparison between N0 and N1-N3 status of breast cancer patients demonstrated that cases with lymph-node metastasis had lower TP63 mRNA expression (P = 0.017, Figure S1F), which might be due to its hypomethylation (Figure S1G).